Enteric fever, predominantly caused by Salmonella typhi and S. paratyphi, continues to pose significant global health challenges. However, advancements in diagnostic methods and treatment strategies have brought about promising changes in managing this infectious disease. This article presents a comprehensive overview of these advancements for healthcare professionals.
Traditional culture methods have been supplemented with serological tests and molecular techniques. The Widal test, though commonly used, suffers from sensitivity and specificity issues. The Typhidot test and Tubex TF test offer better accuracy but are not without limitations. Molecular techniques such as Polymerase Chain Reaction (PCR) and Loop-Mediated Isothermal Amplification (LAMP) have emerged as reliable diagnostic tools, offering rapid, sensitive, and specific detection of S. typhi and S. paratyphi.
Treatment for enteric fever has evolved due to the rising antimicrobial resistance. Fluoroquinolones, the first-line treatment, have seen decreased efficacy due to resistant strains. The World Health Organization now recommends using ceftriaxone or azithromycin as first-line treatments. Vaccination also plays a crucial role in prevention, with the Ty21a and Vi polysaccharide vaccines providing significant protection.
Antimicrobial stewardship programs (ASPs) are increasingly recognized as essential in managing enteric fever. ASPs ensure optimal antibiotic use, minimizing the development of resistance. They also promote the use of rapid diagnostics to guide targeted therapy, reducing unnecessary broad-spectrum antibiotic use.
While challenges persist in managing enteric fever, advancements in diagnostic and treatment strategies offer hope. The integration of molecular diagnostics, new therapeutic guidelines, and antimicrobial stewardship programs can enhance patient outcomes and curb the spread of this infectious disease. It is crucial for healthcare professionals to stay abreast of these developments to provide optimal patient care.
1.
Researchers found that patients undergoing chemotherapy had a higher risk of mixed infections and should begin antibiotic therapy right away.
2.
Study confirms safety and efficacy of higher-dose-per-day radiation for early-stage prostate cancer
3.
Admissions, medical schools, costs, and eligibility requirements information for FNB Onco-Anesthesia.
4.
Radiation therapy can promote amphiregulin, which increases growth of metastases
5.
High Success Rate With Conversion Therapy for Unresectable Gastroesophageal Cancer
1.
Learning from Uncommon Inherited Bleeding Disorder Presentations
2.
Essential Strategies in Hematology for Healthcare Excellence
3.
An Overview Of Leukemia Cutis: What It Is And How To Treat It
4.
All About Ferric Gluconate – The Best Source Of Iron For Anemia
5.
Lymphomatoid Papulosis: What You Need to Know
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
4.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation